Colon to Rectum

Endoscopy. 2024;56(4):291–301

Aoki T, Sadashima E, Kobayashi K, Yamauchi A, Yamada A, Omori J, Ikeya T, Aoyama T, Tominaga N, Sato Y, Kishino T, Ishii N, Sawada T, Murata M, Takao A, Mizukami K, Kinjo K, Fujimori S, Uotani T, Fujita M, Sato H, Hayakawa Y, Fujishiro M, Kaise M, Nagata N; CODE BLUE-J Study collaborators

High-risk stigmata and treatment strategy for acute lower gastrointestinal bleeding: A nationwide study in Japan


Background: The rebleeding risks and outcomes of endoscopic treatment for acute lower gastrointestinal bleeding (ALGIB) may differ depending on the bleeding location, type, and etiology of stigmata of recent hemorrhage (SRH) but have yet to be fully investigated. The authors aimed to identify high-risk endoscopic SRH and to propose an optimal endoscopic treatment strategy.
Methods: They retrospectively analyzed 2699 ALGIB patients with SRH at 49 hospitals (CODE BLUE-J Study), of whom 88.6% received endoscopic treatment.
Results: 30-day rebleeding rates of untreated SRH significantly differed among locations (left colon 15.5% vs. right colon 28.6%) and etiologies (diverticular bleeding 27.5% vs. others [e.g. ulcerative lesions or angioectasia] 8.9%), but not among bleeding types. Endoscopic treatment reduced the overall rebleeding rate (adjusted odds ratio [aOR] = 0.69; 95% confidence interval [CI]: 0.49–0.98), and the treatment effect was significant in right-colon SRH (aOR = 0.46; 95% CI: 0.29–0.72) but not in left-colon SRH. The effect was observed in both active and non-active types but was not statistically significant. Moreover, the effect was significant for diverticular bleeding (aOR = 0.60; 95% CI: 0.41–0.88) but not for other diseases. When focusing on treatment type, the effectiveness was not significantly different between clipping and other modalities for most SRH, whereas ligation was significantly more effective than clipping in right-colon diverticular bleeding.

Conclusions: A population-level endoscopy dataset allowed to identify high-risk endoscopic stigmata of recent hemorrhage (SRH) and propose a simple endoscopic treatment strategy for acute lower gastrointestinal bleeding (ALGIB). Unlike upper gastrointestinal bleeding, the rebleeding risks for ALGIB depend on colonic location, bleeding etiology, and treatment modality.

N. Nagata, Department of Gastroenterological Endoscopy, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan, E-Mail: nnagata_ncgm@yahoo.co.jp

DOI: 10.1055/a-2232-9630

Back to overview

this could be of interest:

A cell-free DNA blood-based test for colorectal cancer screening

N Engl J Med. 2024;390(11):973–83

Early versus late use of vedolizumab in ulcerative colitis: Clinical, endoscopic, and histological outcomes

J Crohns Colitis. 2024;18(4):540–7

More articles on the topic